Ledger.Open graph →
SEC Form D · filed December 28, 2023

Sudo Biosciences, Inc

Offering
$141.0M
Sold
$53.3M
Exemption
Rule 506(b)
Industry
Other Technology
Location
CARMEL, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Shinichiro Fuse · Carmel, INDirectorEdd Fleming · Carmel, INDirectorChris Gagliardi · Carmel, INDirectorScott Byrd · Carmel, INExec · DirectorDavid Johnson · Carmel, INDirectorDaniel Estes · Carmel, INDirectorScott Byrd · Carmel, INExec · DirectorDavid Johnson · Carmel, INDirectorDaniel Estes · Carmel, INDirectorChris Gagliardi · Carmel, INDirectorShinichiro Fuse · Carmel, INDirectorEdd Fleming · Carmel, INDirectorDavid Siemer · Los Angeles, CADirectorTommy Cunningham · Port Richey, FLDirectorLouis F. Malice, Jr · Port Richey, FLDirectorGilson Capilouto · Port Richey, FLDirectorBenjamin Tsai · Los Angeles, CAExec · DirectorAaron H. Yoo · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗